Form 4: AbbVie Inc. Executive Roopal Thakkar Reports Stock Disposal
SEC Form 4
Roopal Thakkar, SVP, CMO, GLOBAL THERAPEUTICS at AbbVie Inc., reported the disposal of 4,914 shares of common stock on February 28, 2024.
Summary
- On February 28, 2024, Roopal Thakkar, SVP, CMO, GLOBAL THERAPEUTICS at AbbVie Inc., disposed of 4,914 shares of common stock at a price of $178.99 per share.
- Following the transaction, Thakkar directly owns 23,259 shares of AbbVie Inc. common stock.
Sentiment
Score: 5
Explanation: This is a neutral report of a stock transaction. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of key personnel at AbbVie Inc.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the change in ownership by a company executive.
Key Dates
| Date | Description |
|---|---|
| 02/28/2024 | Date of transaction: Disposal of AbbVie Inc. common stock. |
| 03/01/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.